Disease/Infection News

RSS

An update of what is currently known about Omicron

On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO's Technical Advisory Group on Virus Evolution (TAG-VE).

29 Nov 2021

European study endorses dashboards for public reporting during the COVID-19 pandemic

Researchers explore the development of COVID-19 dashboards during the first year of the pandemic.

29 Nov 2021

SARS-CoV-2 can directly invade human kidney cells, research shows

Up to 25% of patients' COVID-19 cases involve acute kidney injury—the kidneys' equivalent of a heart attack.

29 Nov 2021

CDC strengthens recommendation on COVID-19 booster doses

Today, CDC is strengthening its recommendation on booster doses for individuals who are 18 years and older. Everyone ages 18 and older should get a booster shot either when they are 6 months after their initial Pfizer or Moderna series or 2 months after their initial J&J vaccine.

29 Nov 2021

Glycosylation and disulfide bonding profile of SARS-CoV-2 spike glycoprotein

Researchers found that virus-like particles produced by co-expression of SARS-CoV-2 S, membrane, envelope, and nucleocapsid proteins contain S glycoproteins, which are modified by complex carbohydrates.

29 Nov 2021

Study: About 1 in 100 COVID-19 patients likely develop central nervous system complications

The largest multi-institutional international study to date on brain complications of COVID-19 has found that approximately one in 100 patients hospitalized with COVID-19 will likely develop complications of the central nervous system.

29 Nov 2021

Extended host range for SARS-CoV-2 variants of concern

Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.

29 Nov 2021

Does vaccine or infection induced immunity better protect against SARS-CoV-2 variants?

A study investigated whether vaccine- or infection-induced immunity is relatively less effective against infection by specific VOCs.

29 Nov 2021

Assessing optimal stroke treatment using CTA imaging

Professor Gilberto Gonzalez discusses using a common imaging technique to decide on the best course of treatment for large vessel occlusion stroke patients.

29 Nov 2021

Study finds atazanavir inhibits main SARS-CoV-2 protease

Research shows that ATV has different antiviral activity compared to PAXLOVID™, encouraging further research.

29 Nov 2021

How COVID-19 protection conferred by infection is modified by vaccination

The authors of a recent study investigated how vaccination, administered before or after the first COVID-19 infection, modifies the protective effect of the previous infection against reinfection.

29 Nov 2021

COVID-19 surges in the USA, Mexico, and Canada

The authors analyzed the waxing and waning patterns of reported SARS-CoV-2 cases in all states and provinces in the USA, Mexico, and Canada, and across all counties in the USA.

29 Nov 2021

Immunity found 6 months after SARS-CoV-2 infection in children

A new study suggests that infection-induced antibodies persist, providing protection for at least six months.

29 Nov 2021

Study: Small percentage of college athletes with COVID-19 develop myocarditis

A small but significant percentage of college athletes with COVID-19 develop myocarditis, a potentially dangerous inflammation of the heart muscle, that can only be seen on cardiac MRI, according to a study being presented today at the annual meeting of the Radiological Society of North America.

29 Nov 2021

Do we need COVID-19 vaccine boosters?

An article published recently in the Journal of Virology explored the science behind COVID-19 vaccine boosters.

29 Nov 2021

Interventions most effective in containing SARS-CoV-2 spread

A new study finds that viral transmission cannot be contained effectively using individual interventions at realistic levels of compliance.

29 Nov 2021

Immunogenicity of modified microparticle-adjuvanted SARS-CoV-2 vaccine

Researchers investigated the immunogenicity of a novel adjuvant comprised of a modified porous silicon microparticle for the SARS-CoV-2 S protein RBD subunit vaccine.

29 Nov 2021

Immigrant uptake of COVID-19 preventive measures

Researchers attempted to understand the factors that make immigrants more vulnerable to COVID-19 related fatalities.

29 Nov 2021

Severe COVID-19 may result in premature aging in recovered patients

As COVID-19 has been found to cause frontal cortex impairment similar to aging, the scientists in a recent study attempted to investigate if severe COVID-19 resulted in aging-related molecular signatures in the brain. The findings from this study are published as a preprint on the medRxiv* server.

28 Nov 2021

Study suggests making COVID vaccines based on Mu variant

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Mu variant (B.1.621, B.1.621.1) has been tagged as a Variant Being Monitored (VBM), and as of August 30, 2021, it had been detected in 39 countries.

28 Nov 2021